Skip to main content
Deutsch

Search

  1. Home
  2. Search

Webseiten-Inhalte

"An Exciting Journey" - MCCA PhD Symposium and SFB F46 Closing Event | MedUni Vienna ...All Events An Exciting Journey Molecular, Cellular and Clinical Allergology (MCCA) PhD Symposium and SFB F46 'Towards prevention and therapy of allergy' Closing Event on Mechanisms of IgE-associated Diseases and Novel Approaches for the Therapy of Allergy and Beyond   Molecular, Cellular and Clinical Allergology (MCCA) is a doctoral program of the Medical University of Vienna and the Veterinary University of Vienna, Austria. SFB F46 'Towards prevention and therapy of allergy' is a special research program located at the Medical University of Vienna and the Karl-Franzens-University of Graz, Austria. Both programs are funded by the FWF Austrian Science Fund. Program 08:30 - 09:00 Registration 09:00 - 09:15 Opening Michaela Fritz, Vice Rector for Research and Innovation, Medical University of Vienna Winfried Pickl, MCCA Speaker Rudolf Valenta, SFB Speaker 09:15 - 10:10 Session One Mohamed... https://www.meduniwien.ac.at/web/en/about-us/events/detail/an-exciting-journey-mcca-phd-symposium-and-sfb-f46-closing-event/?L=3
Melanom: B-Lymphozyten sind entscheidend für erfolgreiche Immuntherapie ... Glatz, Heinz Läubli, Kirsten D. Mertz, Peter Petzelbauer, Thomas Wiesner, Markus Hartl, Winfried F. Pickl, Rajasekharan Somasundaram, Peter Steinberger, Stephan N. Wagner. DOI 10.1038/s41467-019-12160-2 Share Whatsapp Facebook LinkedIn Xing Mail BlueSky Alle News... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2019/news-im-september-2019/melanom-b-lymphozyten-sind-entscheidend-fuer-erfolgreiche-immuntherapie/medizin-wissenschaft/?L=3
Melanom: B-Lymphozyten sind entscheidend für erfolgreiche Immuntherapie ... Glatz, Heinz Läubli, Kirsten D. Mertz, Peter Petzelbauer, Thomas Wiesner, Markus Hartl, Winfried F. Pickl, Rajasekharan Somasundaram, Peter Steinberger, Stephan N. Wagner. DOI 10.1038/s41467-019-12160-2 Share Whatsapp Facebook LinkedIn Xing Mail BlueSky Alle News... https://www.meduniwien.ac.at/web/index.php?id=5287&L=3&tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=2&cHash=7c87eb391d947e09da04b341ae7bf908
Melanom: B-Lymphozyten sind entscheidend für erfolgreiche Immuntherapie ... Glatz, Heinz Läubli, Kirsten D. Mertz, Peter Petzelbauer, Thomas Wiesner, Markus Hartl, Winfried F. Pickl, Rajasekharan Somasundaram, Peter Steinberger, Stephan N. Wagner. DOI 10.1038/s41467-019-12160-2 Share Whatsapp Facebook LinkedIn Xing Mail BlueSky Alle News... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2019/news-im-september-2019/melanom-b-lymphozyten-sind-entscheidend-fuer-erfolgreiche-immuntherapie/?L=3
Melanom: B-Lymphozyten sind entscheidend für erfolgreiche Immuntherapie ... Glatz, Heinz Läubli, Kirsten D. Mertz, Peter Petzelbauer, Thomas Wiesner, Markus Hartl, Winfried F. Pickl, Rajasekharan Somasundaram, Peter Steinberger, Stephan N. Wagner. DOI 10.1038/s41467-019-12160-2 Share Whatsapp Facebook LinkedIn Xing Mail BlueSky Alle News... https://www.meduniwien.ac.at/web/index.php?id=5287&L=3
Melanom: B-Lymphozyten sind entscheidend für erfolgreiche Immuntherapie ... Glatz, Heinz Läubli, Kirsten D. Mertz, Peter Petzelbauer, Thomas Wiesner, Markus Hartl, Winfried F. Pickl, Rajasekharan Somasundaram, Peter Steinberger, Stephan N. Wagner. DOI 10.1038/s41467-019-12160-2 Share Whatsapp Facebook LinkedIn Xing Mail BlueSky Alle News... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2019/news-im-september-2019/melanom-b-lymphozyten-sind-entscheidend-fuer-erfolgreiche-immuntherapie/?cHash=7c87eb391d947e09da04b341ae7bf908&tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=2
Melanom: B-Lymphozyten sind entscheidend für erfolgreiche Immuntherapie ... Glatz, Heinz Läubli, Kirsten D. Mertz, Peter Petzelbauer, Thomas Wiesner, Markus Hartl, Winfried F. Pickl, Rajasekharan Somasundaram, Peter Steinberger, Stephan N. Wagner. DOI 10.1038/s41467-019-12160-2 Share Whatsapp Facebook LinkedIn Xing Mail BlueSky Alle News... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2019/news-im-september-2019/melanom-b-lymphozyten-sind-entscheidend-fuer-erfolgreiche-immuntherapie/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=11&cHash=622a6bf923c31a91e9b4bf779baee136
Melanom: B-Lymphozyten sind entscheidend für erfolgreiche Immuntherapie ... Glatz, Heinz Läubli, Kirsten D. Mertz, Peter Petzelbauer, Thomas Wiesner, Markus Hartl, Winfried F. Pickl, Rajasekharan Somasundaram, Peter Steinberger, Stephan N. Wagner. DOI 10.1038/s41467-019-12160-2 Share Whatsapp Facebook LinkedIn Xing Mail BlueSky Alle News... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2019/news-im-september-2019/melanom-b-lymphozyten-sind-entscheidend-fuer-erfolgreiche-immuntherapie/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=2&cHash=7c87eb391d947e09da04b341ae7bf908
Melanoma: B-lymphocytes crucial for successful immunotherapy ... Petzelbauer, Thomas Wiesner, Markus Hartl, Winfried F. Pickl, Rajasekharan Somasundaram, Peter Steinberger, Stephan N. Wagner. DOI 10.1038/s41467-019-12160-2 Share Whatsapp Facebook LinkedIn Xing Mail BlueSky All News... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2019/news-im-september-2019/melanoma-b-lymphocytes-crucial-for-successful-immunotherapy/?L=3
Melanoma: B-lymphocytes crucial for successful immunotherapy ... Petzelbauer, Thomas Wiesner, Markus Hartl, Winfried F. Pickl, Rajasekharan Somasundaram, Peter Steinberger, Stephan N. Wagner. DOI 10.1038/s41467-019-12160-2 Share Whatsapp Facebook LinkedIn Xing Mail BlueSky All News... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2019/news-im-september-2019/melanoma-b-lymphocytes-crucial-for-successful-immunotherapy/medicine-science/?L=3